Amelioration of Chemotherapy-Induced Toxicity by Cotreatment with AcSDKP, a Tetrapeptide Inhibitor of Hematopoietic Stem Cell Proliferation

1991 ◽  
Vol 628 (1 Negative Regu) ◽  
pp. 126-139 ◽  
Author(s):  
ARTHUR E. BOGDEN ◽  
PATRICE CARDE ◽  
EVELYNE DESCHAMPS DE PAILLETTE ◽  
JACQUES-PIERRE MOREAU ◽  
MAURICE TUBIANA ◽  
...  
1992 ◽  
Vol 47 (9) ◽  
pp. 1324-1332 ◽  
Author(s):  
Jens Freund ◽  
Afroditi Kapurniotu ◽  
Tadeusz A. Holak ◽  
Maryse Lenfant ◽  
Wolfgang Voelter

The solid phase synthesis of the inhibitor of hematopoietic stem cell proliferation, Ac–Ser–Asp–Lys–Pro–OH, and its derivative Ac–Ala–Asp–Lys–Pro–OH is described. 1H and 13C NMR investigations demonstrate that both peptides show no prefered conformation in water solution. Both peptides exist in a Pro-cis-trans equilibrium ratio of 9 (trans) : 1 (cis). Thymosin β4 is believed to be the precursor molecule of the tetrapeptide Ac–SDKP. The attachement of the random coil tetrapeptide to a rigid helical fragment could facilitate its in vivo enzymatic cleavage.


Science ◽  
2010 ◽  
Vol 328 (5986) ◽  
pp. 1689-1693 ◽  
Author(s):  
L. Yvan-Charvet ◽  
T. Pagler ◽  
E. L. Gautier ◽  
S. Avagyan ◽  
R. L. Siry ◽  
...  

2014 ◽  
Vol 42 (8) ◽  
pp. S43
Author(s):  
Seungbum Kim ◽  
Christopher Cogle ◽  
Michael Zingler ◽  
Edward Scott ◽  
Mohan Raizada

Blood ◽  
2015 ◽  
Vol 126 (11) ◽  
pp. 1302-1313 ◽  
Author(s):  
Hui Cheng ◽  
Sha Hao ◽  
Yanfeng Liu ◽  
Yakun Pang ◽  
Shihui Ma ◽  
...  

Key Points Increased quiescence of HSCs and HPCs in leukemogenesis, and reversible suppression of HSCs was observed in leukemic bone marrow. A novel inhibitory role of Egr3 in HSC proliferation was revealed by leukemic infiltration in bone marrow.


Sign in / Sign up

Export Citation Format

Share Document